✦ LIBER ✦

Clinical Practice Considerations and Review of the Literature for the Use of DPP-4 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease

✍ Scribed by Ramirez, German; Morrison, Anthony; Bittle, Polly

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sitagliptin, a DPP-4 inhibitor for the t

✍ Karasik, Avraham; Aschner, Pablo; Katzeff, Harvey; Davies, Michael J.; Stein, Pe 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 462 KB

The Relationship Between Severity Of Chr

✍ Lage, M.J; Boye, K.S; Paczkowski, R.; Curtis, B. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Efficacy and Tolerability of the DPP-4 I

✍ DeFronzo, R. A.; Burant, C. F.; Fleck, P.; Wilson, C.; Mekki, Q.; Pratley, R. E. 📂 Article 📅 2012 🏛 Endocrine Society 🌐 English ⚖ 427 KB

Antidiabetic medication use and prevalen

✍ Carol E. Koro; Bo Hyen Lee; Steve J. Bowlin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Pharmacokinetics, safety, and efficacy o

✍ Giorda, Carlo B.; Nada, Elisa; Tartaglino, Barbara 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 336 KB

DPP-4 inhibitors and GLP-1 analogues: fo

✍ S. Halimi 📂 Article 📅 2008 🏛 Masson Editeur 🌐 French ⚖ 451 KB